Clarfeld Financial Advisors’s Quest Diagnostics DGX Stock Holding History

Clarfeld Financial Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$14K	Buy	+158	New	+$14.8K	0.01%	187

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Clarfeld Financial Advisors's DGX Position: Q4 2018 in Review

Clarfeld Financial Advisors opened a new position in Quest Diagnostics (DGX) in Q4 2018: 158 shares worth $14K. The stake represents 0.01% of the portfolio and ranks #187 among its holdings.

625 funds tracked by Wall St. Rank hold DGX as of Q4 2018.

Clarfeld Financial Advisors held 158 shares of Quest Diagnostics worth $14K as of Q4 2018.
Quest Diagnostics was a new Clarfeld Financial Advisors position in Q4 2018.
Quest Diagnostics made up 0.01% of Clarfeld Financial Advisors's portfolio in Q4 2018, its #187 holding.
625 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2018.

Based on Clarfeld Financial Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.